WILLIAM G WIERDA to Propensity Score
This is a "connection" page, showing publications WILLIAM G WIERDA has written about Propensity Score.
Connection Strength
0.104
-
Frontline therapy with high-dose imatinib versus second generation tyrosine kinase inhibitor in patients with chronic-phase chronic myeloid leukemia - a propensity score analysis. Haematologica. 2016 08; 101(8):e324-7.
Score: 0.104